Tagungen und Workshops zum Thema Infektiologie

Biologie,    Molekularbiologie

Biologie,    Molekularbiologie

Swiss Institute of Allergy and Asthma Research (SIAF)

WIRM will be focused on Immune Activation, Effector Functions and Immune Tolerance with a special focus on Autoimmunity and Allergy . Reduced Early Registration Deadline is 2 December 2019. Abstract Submission Deadline is 2 December 2019.

Event Manager;     Tel.: [0041 81 410 08 42];     Email: wirminfo@wirm.ch

Innate immune response, Dendritic cell subsets and immune regulation, B cell subsets and immune regulation, NK cells and NK-T cells, Eosinophils, Basophils and Neutrophils, Innate lymphoid cells, Transcriptional regulation of immune responses, Development of effector and regulatory T cells, T and B cell memory and immune regulation, Chemokines and receptors in immune response, Apoptosis in the regulation of immune responses, The role of microRNAs in immune regulation and effector functions, Role of epithelial cells and other resident tissue cells, Epigenetic mechanism of immune response, Metabolism and immunity, Hygiene hypothesis in immune regulation, Regulatory and effector T and B cell subsets and cytokines: from bench to bedside, Immune response to parasites, Tumor antigen-specific immune regulation, Autoimmunity, Neuroimmunology, Allergy and asthma, Organ transplantation, Experimental models of inducing and breaking peripheral tolerance, Mucosal tolerance and intestinal homeostasis, Development of novel vaccines and drugs, „Biologicals“ and immune response, Cellular therapies including stem cell therapies, Regenerative medicine and immune system, Precision Medicine, Novel immune imaging techniques.

Immunologie und Allergie,    Dermatologie

The meeting will focus on one of the most important aspects of EVs, their role in infectious human diseases. The aim of the proposed conference is to improve our understanding of the mechanisms of this involvement and to evaluate EVs as potential therapeutic targets.

Conference Manager;     Tel.: [+441638724137];     Email: admin@fusion-conferences.com

extracellular vesicles, Human Infectious Diseases, microbiology, translational medicine, evs,

Fusion Conferences Ltd

Extracellular vesicles (EVs), which are generated by almost all living cells, are now considered to be an important system of cell–cell communication. A large volume of data has been published on EVs in different fields of biology and medicine, from immunology to marine biology. These data are discussed at large international meetings that gather thousands of researchers. However, there is still a need for more-focused meetings at which the importance and reliability of the data should be evaluated by a narrow circle of experts. Here, we propose to organize a small conference that will focus on one of the most important aspects of EVs, their role in infectious human diseases. The aim of the proposed conference is to improve our understanding of the mechanisms of this involvement and to evaluate EVs as potential therapeutic targets.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

Extracellular vesicles, EVs, Human Disease, Infectious Human Disease, Exosomes

Biologie,    Stammzellforschung und -therapie

Harvard Medical School

This comprehensive Harvard Medical School CME program—one of the highest-rated HMS CME courses-- ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven: Strategies for optimal decision-making in the prevention, diagnosis and treatment of infectious diseases -- Newer antimicrobials and treatment strategies for highly resistant bacterial infections -- Prevention and treatment of infection in immunocompromised hosts -- State-of-the-art approaches to common infections -- Clinical approaches to complex, rare, "don't-miss" infections -- New, evolving, and emerging infectious diseases -- Update on antifungal diagnostics and therapy -- Optimal management of Staph aureus infections -- Infections in persons with substance use disorders -- What’s new in HIV management and prevention -- Musculoskeletal infectious diseases -- ID for hospital medicine specialists -- Workshop on resistant and difficult-to-treat infections -- Workshop on antimicrobial stewardship -- As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work. Please visit the course website at https://id.hmscme.com for a complete schedule and a comprehensive list of course highlights.

Tel.: [617-384-8600];     Email: CEPrograms@hms.harvard.edu

Harvard, infections, comprehensive, CME, antimicrobials, immunocompromised hosts, antifungals, HIV, resistant infections, antimicrobial stewardship, substance use disorders, emerging infectious diseases, zoonoses, tick-borne, ENT, Vaccines, Clostridium difficile, Zika, EEE, sexually transmitted infections, Hepatitis, MRSA, OPAT, detection, diagnosis, treatment

Tel.: [+49 89 890677 0];     Email: info@cocs.de

Organising Secretariat - Ashfield Healthcare Communications

The HIV Glasgow programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community.

Email: hivglasgow@ashfieldhealthcare.com